Cite
HARVARD Citation
Chang, W. et al. (2020). High Risk of Clinical Relapse in Patients With Chronic Hepatitis B Virus Infection After Cessation of Prophylactic Antiviral Therapy for Rituximab-Containing Chemotherapy. Journal of infectious diseases. pp. 1345-1352. [Online].